Rebecca joined The Mark Foundation as Scientific Program Director in November 2017. She came to The Mark Foundation from D. E. Shaw Research, a firm engaged in scientific research and technological development in the field of computational biochemistry. Rebecca previously conducted post-doctoral research at New York University and Memorial Sloan Kettering Cancer Center, focusing on the use of proteomics technology for basic and translational cancer research. Rebecca holds an SB in Biology from MIT and a PhD in Biology from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory. She also founded a company that provided scientific editing, grant writing, and consulting services to the life sciences research community.